July 7, 2020 / 4:28 PM / a month ago

BRIEF-Biomed Lublin To Issue Up To 6.0 Mln R Series Shares, Launch ABB Process

July 7 (Reuters) - Biomed Lublin Wytwornia Surowic i Szczepionek SA:

* MANAGEMENT RESOLVES TO INCREASE SHARE CAPITAL BY UP TO 0.6 MILLION ZLOTYS VIA ISSUE OF 6.0 MILLION R SERIES SHARES WITHOUT PREEMPTIVE RIGHTS

* PURPOSE OF ISSUE IS RAISING CAPITAL FOR BCG TUBERCULOSIS VACCINE AND ONKO BCG DEVELOPMENT

* R SERIES SHARES WILL BE OFFERED UNDER PRIVATE SUBSCRIPTION TO INVESTORS SELECTED IN BOOK BUILDING PROCESS

* PURPOSE OF ISSUE IS ALSO RAISING CAPITAL TO REPAY OBLIGATIONS TO POLISH AGENCY FOR ENTERPRISE DEVELOPMENT AND ALL REMAINING ARRANGEMENT OBLIGATIONS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below